Suzetrigine is the first drug to be approved in a new class of pain management medicines. It will serve as a non-opioid treatment for moderate to severe acute pain in adults. Experts with the ...

Doerring, M.D., former FDA medical officer in the division of psychiatry and the founder and CEO of TaperClinic, he shares ...

The medication landscape for pain management has evolved dramatically ... Topical treatments have gained new prominence, allowing medication to be applied directly to painful areas rather than ...

FDA approval of a novel non-opioid analgesic will hopefully address the needs of many patients with acute pain and improve ...

Researchers have developed a new type of oral painkiller for chronic abdominal pain, inspired by the peptide hormone oxytocin ...

Only around one in every 10 treatments were found to be effective in relieving lower back pain, according to a new study ...

Why this product may help pain Experienced users or people who have found lower CBD doses not effective enough for pain management may ... prescription pain medications, research into the benefits ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

To read more letters to the editor, go to oregonlive.com/opinion.

A tool that uses artificial intelligence to pinpoint the delivery of pain management drugs to an injury site is being developed by Army researchers. The aim is to allow personnel who may have ...